LDK Solar receives CBD loan for polysilicon upgrade

Share

The Chinese photovoltaic manufacturer says investments will primarily be made into hydrochlorination technology, which is said to be "critical" to reducing silicon manufacturing costs.

In a statement released, the company states, "LDK Solar plans to drawdown the loan as market conditions improve and the necessary equipment is ready for its use."

Overall, LDK Solar Co., Ltd says it has invested more than RMB 12 billion in its Mahong Polysilicon Plant. These investments, it adds, are the key cause for its high debt ratio.

In the past few months, the company has sold off over 30% of its stock, in a bid to reduce mounting debts, rumored to be around $3.1 billion. Transactions include a 12% stake sold to Fulai Investments Ltd, and a 19.9% stake to the the Heng Rui Xin Energy Company.

Popular content

This content is protected by copyright and may not be reused. If you want to cooperate with us and would like to reuse some of our content, please contact: editors@pv-magazine.com.

Share

Related content

Elsewhere on pv magazine...

Leave a Reply

Please be mindful of our community standards.

Your email address will not be published. Required fields are marked *

By submitting this form you agree to pv magazine using your data for the purposes of publishing your comment.

Your personal data will only be disclosed or otherwise transmitted to third parties for the purposes of spam filtering or if this is necessary for technical maintenance of the website. Any other transfer to third parties will not take place unless this is justified on the basis of applicable data protection regulations or if pv magazine is legally obliged to do so.

You may revoke this consent at any time with effect for the future, in which case your personal data will be deleted immediately. Otherwise, your data will be deleted if pv magazine has processed your request or the purpose of data storage is fulfilled.

Further information on data privacy can be found in our Data Protection Policy.